SHANGHAI, Feb 4 (Bernama-BUSINESS WIRE) -- In the summer of 2015, an event drew record-breaking single-day crowds of over 170,000 professionals to Shanghai solely for the healthcare sector. It was a mega trade event combining the top medical and pharmaceutical events in China, the Health Industry Summit.
With the start of China’s 13th Five-year plan in 2016, the “Health China 2020” program focusing on the co-development of healthcare, pharmaceutical production and health insurance, separation of prescribing and dispensing and the hierarchical medical system has become a national strategy. It comes as one additional boost to many already eyeing the opportunities from the increasingly ageing population and the expected population boom in light of the reversal of the single-child policy. By the end of 2015, over 100 traditionally non-healthcare-oriented traded companies in China had taken healthcare as one of their investment and development priorities, many renaming their company to reflect this new focus, not to mention well-known giants like Lenovo, Fosun, and Wanda Group driving a stake into key portions of the sector.
http://mrem.bernama.com/viewsm.php?idm=26165
No comments:
Post a Comment